When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Moment Of Truth Approaches For Moderna's RSV Vaccine
Pfizer Inc.
2024-06-18 03:42:39 ET
Summary
Moderna's RSV vaccine has been approved by the FDA, but it faces competition from GSK and PFE's offerings.
A June 26 meeting of the Advisory Committee on Immunization Practices is a near-term catalyst. MRNA is hoping for parity with GSK/PFE when it comes to recommendations for RSV vaccines.
With regards to differentiation, MRNA's RSV vaccine comes as a pre-filled syringe, which could help it to carve out its share of the market.